Validation of an analytical method using HPLC–MS/MS to quantify osimertinib in human plasma and supplementary stability results
出版年份 2019 全文链接
标题
Validation of an analytical method using HPLC–MS/MS to quantify osimertinib in human plasma and supplementary stability results
作者
关键词
-
出版物
BIOMEDICAL CHROMATOGRAPHY
Volume 34, Issue 4, Pages -
出版商
Wiley
发表日期
2019-12-06
DOI
10.1002/bmc.4771
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Quantification of afatinib, alectinib, crizotinib and osimertinib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry; focusing on the stability of osimertinib
- (2019) G.D. Marijn Veerman et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Development of an LC–MS/MS-based method for quantitation of osimertinib in human plasma and cerebrospinal fluid
- (2019) Kei Irie et al. Bioanalysis
- Determination of osimertinib in human plasma, urine and cerebrospinal fluid
- (2019) Richard Mitchell et al. Bioanalysis
- Development and validation of a liquid chromatography-tandem mass spectrometry assay for nine oral anticancer drugs in human plasma
- (2019) Julie M. Janssen et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients
- (2018) Rafael Reis et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fast and Straightforward Method for the Quantification of Pazopanib in Human Plasma Using LC-MS/MS
- (2018) Remy B. Verheijen et al. THERAPEUTIC DRUG MONITORING
- Pharmacokinetics of Osimertinib in Chinese Patients With Advanced NSCLC: A Phase 1 Study
- (2017) Hongyun Zhao et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
- (2017) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinical studies
- (2016) David Planchard et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Liquid chromatography–tandem mass spectrometric assay for the T790M mutant EGFR inhibitor osimertinib (AZD9291) in human plasma
- (2016) Johannes J.M. Rood et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
- (2014) D. A. E. Cross et al. Cancer Discovery
- A validated assay for the simultaneous quantification of six tyrosine kinase inhibitors and two active metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry
- (2013) Nielka P. van Erp et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography–tandem mass spectrometry (LC/MS–MS)
- (2012) Mukul Minocha et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started